Preclinical Evaluation of theEffects of Trazpiroben (TAK-906), a Novel, Potent Dopamine D2/D3 Receptor Antagonist for the Management of Gastroparesis
2021 ◽
pp. JPET-AR-2021-000698
2001 ◽
Vol 418
(3)
◽
pp. 201-206
◽
Keyword(s):
2013 ◽
Vol 36
(2)
◽
pp. 68-69
◽
2009 ◽
Vol 620
(1-3)
◽
pp. 27-35
◽
Keyword(s):
2009 ◽
Vol 607
(1-3)
◽
pp. 74-83
◽
Keyword(s):
2009 ◽
Vol 602
(1)
◽
pp. 66-72
◽
Keyword(s):
2009 ◽
Vol 2
(2)
◽
pp. 86-92
Keyword(s):
2005 ◽
Vol 58
(11)
◽
pp. 908-912
◽
Keyword(s):